1:1 Bonus Shares: Record Date Confirmed By The Board; What Technical Pattern Hints For This Pharma Stock?

Anuh Pharma Limited is an Indian firm that manufactures active pharmaceutical ingredients, or APIs, in bulk. It belongs to the SK Group and is a major producer of anti-TB and macrolides as well as other important APIs including corticosteroids, anti-malarials, and anti-bacterials.The firm is well-known for manufacturing pyrazinamide, higher macrolides like azithromycin, and erythromycin and its salts. A public limited company, Anuh Pharma Limited is listed on both the Bombay Stock Exchange and the National Stock Exchange.

Anuh Pharma Bonus Shares

"This is further to our intimation dated 07th July, 2025, Please note that the Members of the Company have approved the issue of Bonus Shares in the ratio of 1:1 i.e. 1 (One) new fully paid-up Equity Shares of Rs 5/- each for every 1 (One) existing fully paid-up Equity Share of the Company and that the Bonus Shares so distributed shall, for all purpose, be treated as an increase in the paid-up capital of the Company. We further wish to inform that the Board of Directors of the Company have approved and fixed 15th July, 2025 as the Record Date for the purpose deciding the Members who shall be eligible to the allotment of the Bonus Shares as per ratio mentioned above," said Anuh Pharma in a stock exchange filing.

"The fully paid-up Bonus Shares shall be distributed to the Members of the Company, whose names appear on the Register of Members as on 15th July, 2025, of the Company. The Bonus Shares so allotted shall rank pari-passu in all respects with the fully paid-up Equity Shares of the Company as existing on 15th July, 2025," Anuh Pharma further informed stock exchanges on 07th July, 2025.

Anuh Pharma Financials

According to a Business Standard piece, Anuh Pharma's net profit decreased 18.88% to Rs 12.46 crore in the quarter that ended in March 2025 from Rs 15.36 crore in the quarter that ended in March 2024. In Q4FY25, sales increased 20.90% to Rs 198.14 crore from Rs 163.89 crore in Q4FY24. In the year ending in March 2025, net profit decreased 21.16% to Rs 47.35 crore, compared to Rs 60.06 crore in the year ending in March 2024. Compared to Rs 647.00 crore for the entirety of FY24, sales increased by 2.24% to Rs 661.51 crore in FY25.

Anuh Pharma Share Price Target

"Anuh Pharma stock price is bearish on the Daily charts with strong resistance at 230. A Daily close below support of 214 could lead to a target of 200 in the near term," commented A R Ramachandran, independent research analyst.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor GoodReturns. The author, nor the brokerage firm nor GoodReturns would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.